Hugo机器人系统在克罗恩病回盲部切除术中降低中转开腹与再入院率
该回顾性队列研究纳入2003至2025年单中心1392例克罗恩病回盲部切除术患者,比较机器人(62例)、腹腔镜(623例)与开腹(707例)三种术式。经倾向性评分匹配和多因素回归调整后,Hugo机器人系统较腹腔镜显著降低中转开腹率、30天再入院率和严重并发症风险,并缩短住院时间,且不增加手术时间。
要点
- 机器人组中转开腹率1.6%,显著低于腹腔镜组的15.2%(p=0.001)。
- 匹配分析显示机器人组30天再入院绝对风险降低16.1%(p=0.025)。
- 机器人组严重并发症(Clavien-Dindo≥III)风险显著低于腹腔镜(p=0.037)。
核心结论
- Hugo机器人系统行克罗恩病回盲部切除术安全有效,可显著降低中转开腹率和再入院率,缩短住院时间,且不牺牲手术效率。
研究设计与样本
- 回顾性队列研究,数据来自2003年1月至2025年6月单中心前瞻性维护数据库,共纳入1392例克罗恩病回盲部切除术患者,按术式分为机器人组62例、腹腔镜组623例、开腹组707例。
- 采用多因素回归、1:1和1:4倾向性评分匹配及G-computation方法比较术后并发症、再入院、中转率和住院时间。
主要发现
- 机器人组中转开腹率为1.6%,腹腔镜组为15.2%(p=0.001)。
- 调整后机器人手术与中转开腹风险降低89%独立相关(调整OR 0.11;95%CI 0.02-0.77;p=0.027)。
- 主要倾向性评分匹配分析中,机器人组30天再入院绝对风险降低16.1%(p=0.025),严重并发症(Clavien-Dindo≥III)风险显著低于腹腔镜组(p=0.037)。
- 敏感性分析证实机器人组住院时间较腹腔镜组(p=0.049)和开腹组(p<0.001)均显著缩短。
- 调整后机器人组与腹腔镜组手术时间相当(p=0.572)。
临床怎么用
- 对于克罗恩病回盲部切除术,Hugo机器人系统可作为传统腹腔镜和开腹手术的安全有效替代方案。
- 机器人approach可能特别有利于降低中转开腹风险,从而减少再入院和缩短住院时间。
局限性
- 本研究为单中心回顾性设计,存在选择偏倚可能。
- 机器人组样本量较小(62例),结论需更大规模前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robotic surgery is increasingly adopted in inflammatory bowel disease to address the technical limitations of conventional laparoscopy. This study aimed to compare the perioperative outcomes of robotic ileocecal resection for Crohn's disease (CD) using the Hugo™ RAS system against laparoscopic and open approaches. METHODS: Data were retrospectively collected from a prospectively maintained database of patients undergoing ileocecal resection for CD between January 2003 and June 2025 at a tertiary referral center. Patients were stratified by surgical approach: robotic, laparoscopic, or open. Multivariable regression, 1:1 and 1:4 propensity score matching (PSM), and G-computation were utilized to compare postoperative complications, readmissions, conversion rates, and length of hospital stay (LOS). RESULTS: A total of 1392 patients were included (62 robotic, 623 laparoscopic, 707 open). The robotic approach was associated with a significantly lower rate of conversion to open surgery compared to laparoscopy (1.6% vs 15.2%; p = 0.001). After adjustment, robotic surgery remained independently associated with an 89% reduction in the odds of conversion (adjusted OR 0.11; 95% CI 0.02-0.77; p = 0.027). In the primary PSM analysis, the robotic group demonstrated a 16.1% absolute risk reduction in 30-day readmissions (p = 0.025) and a significantly lower risk of severe complications (Clavien-Dindo ≥ III) compared to laparoscopy (p = 0.037). Sensitivity analyses confirmed a statistically significant reduction in LOS for the robotic group compared to both laparoscopic (p = 0.049) and Open (p < 0.001) approaches. Adjusted operative times were comparable between robotic and laparoscopic procedures (p = 0.572). CONCLUSION: Robotic ileocecal resection using the Hugo™ RAS system is a safe and effective alternative to conventional techniques. It offers distinct clinical advantages, including marked reductions in conversion rates and hospital readmissions, as well as a shorter length of stay, without compromising operative efficiency.
引用
- Violante T, Cardelli S, Calini G, et al. Reduced conversion and readmission rates in robotic ileocecal resection for Crohn's disease: a propensity-matched analysis of the Hugo™ RAS system. Surg Endosc. 2026. PMID: 42257950. doi:10.1007/s00464-026-12775-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。